Cargando…
Nontuberculous Mycobacteria in Cystic Fibrosis
Nontuberculous mycobacteria (NTM) are found in approximately 10 % of cystic fibrosis (CF) patients, but only a portion will develop NTM disease. The management of CF lung disease should be optimized, including antibiotic therapy targeted to the individual’s usual airway bacteria, prior to considerin...
Autores principales: | Skolnik, Kate, Kirkpatrick, Gordon, Quon, Bradley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155018/ https://www.ncbi.nlm.nih.gov/pubmed/28035194 http://dx.doi.org/10.1007/s40506-016-0092-6 |
Ejemplares similares
-
Treatment of Latent Tuberculosis Infection
por: Tang, Patrick, et al.
Publicado: (2017) -
Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis
por: Prieto, Miguel D., et al.
Publicado: (2023) -
Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis
por: Qvist, Tavs, et al.
Publicado: (2014) -
Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018) -
Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis
por: Al-momani, H., et al.
Publicado: (2017)